Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

ExpreS2ion Biotechnologies – Reverse share split and malaria commercialization

Af Michael FriisHead of Equities
30.10.2024, 13.55
ExpreS2ion Biotech Holding

On 16 October 2024, ExpreS2ion Biotechnologies announced that the company had signed a term sheet with Serum Institute of India Private Limited (SIIPL), a leading global vaccine manufacturer, to commercialize malaria vaccines currently in Phase I and Phase II.

On 21 October 2024, a reverse share split of the company’s shares was resolved, whereby 40 existing shares would be consolidated into 1 share, which is effective today.

In connection with these announcements, we sat down with the company’s CEO Bent Frandsen to get more flavor on the news. Hear more about the potential partner on the malaria vaccines and the next steps, as well as the rationale behind carrying out a reverse share-split in the video. 

ExpreS2ion Biotechnologies is a Danish pharmaceutical company, which focuses on the development of vaccines through the use of its non-viral Drosophila S2 cells-based expression system.

Disclaimer: HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Digital IR/Corporate Visibility subscription agreement. /Michael Friis 13:53, 30 October 2024.

Recent videos

DB
Danske Bank – Præsentation af regnskabet for 2. kvartal 2025
13.08.2025, 14.30 Danske Bank
Wi
Wirtek – Presentation of Q2 2025 Interim Report
13.08.2025, 13.30 Wirtek
NYAB
NYAB Q2´25: Strong Q2 sets tone for H2
13.08.2025, 12.53 NYAB
Ol
Olvi Oyj, Webcast, Q2'25
13.08.2025, 11.00 Olvi
CC
Copenhagen Capital – Præsentation af H1 og opdatering på strategiplaner
13.08.2025, 11.00 Copenhagen Capital
Vis alle videoer
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Privatlivspræferencer

Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.